These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 21309721

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW, Appfelstaedt J, Zaahl MG.
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
    Bugalho MJ, Domingues R, Santos JR, Catarino AL, Sobrinho L.
    Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
    [Abstract] [Full Text] [Related]

  • 9. Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic.
    Jindrichová S, Vcelák J, Vlcek P, Neradilová M, Nemec J, Bendlová B.
    J Endocrinol; 2004 Nov; 183(2):257-65. PubMed ID: 15531714
    [Abstract] [Full Text] [Related]

  • 10. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y, Zhao Y, Cui B, Gu L, Zhu S, Li J, Liu J, Yin M, Zhao T, Yin Z, Yu C, Chen C, Wang L, Xiao B, Hong J, Zhang Y, Tang Z, Wang S, Li X, Ning G.
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
    Menon MM, Simha MR.
    Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
    [Abstract] [Full Text] [Related]

  • 13. [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor].
    Amosenko FA, Brzhezovskiĭ VZh, Liubchenko LN, Shabanov MA, Kozlova VM, Vanushko VE, Kazubskaia TP, Gar'kavtseva RF, Kalinin VN.
    Genetika; 2003 Jun; 39(6):847-54. PubMed ID: 12884527
    [Abstract] [Full Text] [Related]

  • 14. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G, Saeger HD, Roesner D, Schackert HK.
    Klin Padiatr; 2004 Jun; 216(5):270-6. PubMed ID: 15455293
    [Abstract] [Full Text] [Related]

  • 15. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL, Gosnell J, Elston MS, Saurine TJ, Richardson AL, Delbridge LW, Aglen JV, Robinson BG.
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [Abstract] [Full Text] [Related]

  • 16. Change in the spectrum of RET mutations diagnosed between 1994 and 2006.
    Frank-Raue K, Rondot S, Schulze E, Raue F.
    Clin Lab; 2007 Dec; 53(5-6):273-82. PubMed ID: 17605401
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds.
    Dvorakova S, Vaclavikova E, Ryska A, Cap J, Vlcek P, Duskova J, Kodetova D, Holub V, Novak Z, Bendlova B.
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):192-6. PubMed ID: 16705552
    [Abstract] [Full Text] [Related]

  • 19. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
    Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A, Robledo M, Biarnes J, Barontini M, Links TP, de Groot JW, Dvorakova S, Peczkowska M, Rybicki LA, Sullivan M, Raue F, Zosin I, Eng C, Neumann HP.
    Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
    [Abstract] [Full Text] [Related]

  • 20. A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families.
    Marsh DJ, Robinson BG, Andrew S, Richardson AL, Pojer R, Schnitzler M, Mulligan LM, Hyland VJ.
    Genomics; 1994 Sep 15; 23(2):477-9. PubMed ID: 7835899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.